Guardant Health Prices Upsized $350.0 Million Convertible Senior Notes Offering
PALO ALTO, Calif.–(BUSINESS WIRE)–Guardant Health, Inc. (“Guardant Health”) (Nasdaq: GH), a leading precision oncology company, today announced... Read more.
Guardant Health Announces Pricing of Upsized Public Offering of Common Stock
PALO ALTO, Calif.–(BUSINESS WIRE)–Guardant Health, Inc. (“Guardant Health”) (Nasdaq: GH), a leading precision oncology company, today announced... Read more.
Tokyo Metropolitan Government Selects Japan Airlines Consortium to Join First Phase of “eVTOL Implementation Program” Featuring Archer’s Midnight Aircraft
Japan Airlines-led consortium, which features Archer’s Midnight as the intended aircraft, is selected by the Tokyo Metropolitan Government to participate... Read more.
Phillips & Cohen Associates’ Parent Company, PCA Global Ventures, Announces Strategic Leadership Appointments
MANCHESTER, United Kingdom–(BUSINESS WIRE)–PCA Global Ventures, the parent company of Phillips & Cohen Associates, Ardent Credit Services, Invenio... Read more.
MaaT Pharma Presents Updated Preclinical Data at SITC Annual Meeting Demonstrating Immune Activation and Anti-Tumor Activity of MaaT034
LYON, France–(BUSINESS WIRE)–$MAAT #ASH–Regulatory News: MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology... Read more.
Galderma Receives U.S. FDA Approval for Restylane® Lyft™ for the Enhancement of the Chin Profile
This approval is based on results showing the safety and effectiveness of Restylane Lyft in enhancing the chin profile, with high patient satisfaction and long-lasting... Read more.
Innate Pharma Announces Conference Call and Webcast for Third Quarter 2025 Results and Business Updates
MARSEILLE, France–(BUSINESS WIRE)–#immunotherapy–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate”... Read more.
Prodapt Appoints Dhanashree Bhat as Chief Delivery Officer
CHENNAI, India & DALLAS–(BUSINESS WIRE)–#AI–Prodapt, a leading global technology services provider, announced the appointment of Dhanashree... Read more.
Kodiak Gas Services Clarifies Third Quarter 2025 Earnings Call Timing
THE WOODLANDS, Texas–(BUSINESS WIRE)–As noted in the press release dated October 23, 2025, Kodiak Gas Services, Inc. (NYSE: KGS), (“Kodiak”... Read more.
Radiant Biotherapeutics to Present New Data from Lead Oncology Program at SITC 2025 Annual Meeting
RBT-101, Radiant’s lead oncology program and 4-1BB agonist, demonstrated robust, durable and complete tumor regression without liver toxicity in MC38 colorectal... Read more.